Imperial College London
- Published: Friday, 11 October 2013 15:00
Consistently rated amongst the world's best universities, Imperial College London is a science-based institution with a reputation for excellence in teaching and research that attracts 14,000 students and 6,000 staff of the highest international quality.
Innovative research at the College explores the interface between science, medicine, engineering and business, delivering practical solutions that improve quality of life and the environment - underpinned by a dynamic enterprise culture that seeks to innovate at every opportunity.
Since its foundation in 1907, Imperial's contributions to society have included the discovery of penicillin, the development of holography and the foundations of fibre optics. This commitment to the application of research for the benefit of all continues today, with current focuses including interdisciplinary collaborations to improve global health, tackle climate change, develop sustainable sources of energy and address security challenges. Our staff, students and alumni can be found all over the world, applying their distinctive knowledge, skills and motivation to advance some of the most difficult scientific and technological issues that we face, not just today but in the future.
We continue to pioneer new ways of translating our work into practice both in the UK and internationally – the formation, in 2007, between Imperial College London and Imperial College Healthcare NHS Trust of the UK's first Academic Health Science Centre being just one example of this. This unique partnership aims to improve the quality of life of patients and populations by taking new discoveries and translating them into new therapies as quickly as possible. The new Francis Crick Institute in London, of which Imperial is a founding member, is set to be the biggest centre for biomedical research and innovation in Europe.
As part of Imperial’s vision for the future, the College has launched Imperial West, a major new campus in White City, which will provide multidisciplinary research space, co-locating world class researchers, businesses and higher education partners to create value from ideas, for the benefit of society on a local, national and global scale.
Three global pharmaceutical companies (AstraZeneca, GlaxoSmithKline, Johnson & Johnson Innovation) and the technology transfer offices of three world-leading universities (Imperial College London, University of Cambridge and UCL) have joined forces with a combined £40 million to create the Apollo Therapeutics Fund.
The Centre for Business Research (CBR)completed the first ever national survey of all academics at all UK universities in all disciplines.
After the 2034: Tech Foresight event Prof. Graeme Reid, Prof. David Klug and Prof. Neil Alford share their views.
The aspiration is for Snowball Metrics to become global standards that are endorsed by research institutions internationally.
Alex Ayad introduces Foresight Practice's annual conference and discusses the rapidly evolving technology of today and what the future holds.
Imperial College London's Q&A with Russ Cummings. He discusses everything from turning ideas into businesses and how his will impact the university.